Nobody here but me and my microbes
A study by UK scientists in Nature Biotechnology indicates that ushering in the era of genetic engineering and personalised medicine may be more involved than anyone had imagined. It turns out that most of the cells in our body are bacteria, fungi and viruses. More than 500 species of bacteria exist in the human body, making up more than 100 trillion cells — compared to a mere several trillion human cells. We humans, it seems, are “super-organisms” who share our bodies with an abundant quantity of other life forms.
It follows that much of the genetic material in our bodies belong to bacteria and this must be taken into account in the development of biotechnology cures. The decoding of the human genome is only a small first step towards understanding how the body interacts with its environment.
Professor Ian Wilson, of the drug giant Astra Zeneca, says that the human super-organism concept “could have a huge impact on how we develop drugs, as individuals can have very different responses to drug metabolism and toxicity.”
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...